Recently, the High-tech Enterprise Certificate, for high-tech enterprises with the government's key support and having strong capability of research and development and innovation, was issued jointly by Beijing Municipal Science & Technology Commission, Beijing Municipal Finance Bureau, Beijing Municipal Office, SAT, and Beijing Local Taxation Bureau, to recognize, encourage and guide the continuous innovation of enterprises. As a leading company focused on cancer precision medicine, Genetron Health has finally been awarded the certificate after being inspected and evaluated at all levels of indicators such as core independent intellectual property rights, and the ability to apply the scientific and technological achievements.
Since Genetron Health was founded, it has always been adhering to the development on both scientific research and clinical service, as well as the continuous innovation at the core technical level.
All members of the expert team of Genetron Health are from world-class universities and research institutions. The team has the professional capability of multidisciplinary complementation, creating a multidisciplinary collaboration system for cancer precision medicine. Besides, Genetron Health has applied for and hosted several national and local major scientific research projects, such as the "Brain Science Special Program" of the Science & Technology Commission, the "Capital Special Program" and the national precision medicine program. In addition, to continuously introduce new testing products, Genetron Health attaches great importance to the cooperation with national major medical institutions and scientific research institutions. So far, it has carried out nearly a hundred cooperated programs, including genealogical analysis, individualized precision medical solutions, somatic cell mutation feature test, biomarker screening, etc., by which it becomes possible to make the leading technologies applicable quickly to facilitate clinical applications.